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COMMENTARYThe molecular fingerprint of bicuspid aortopathyPaul W. M. Fedak, MD, PhD, FRCSC,a,b and Subodh Verma, MD, PhD, FRCSCc,dSurgical treatments for thoracic aneurysmal diseases have
evolved rapidly. Technical innovations in open repairs
(David aortic valve–sparing root replacement) and minimal
access endovascular procedures (thoracic endovascular aor-
tic repair) have improved patient outcomes substantially.
Unfortunately, our understanding of the molecular and
cellular mechanisms that trigger aortic remodeling and
aneurysm formation have not been as progressive as the sur-
gical approaches to the same problem. The complex aortop-
athy associated with bicuspid aortic valves is of growing
interest to both surgeons and scientists.1 Others and we
have demonstrated the activation of unique molecular path-
ways that control extracellular matrix (ECM) regulation in
patients that may trigger and coordinate the progressive aor-
tic thinning and dilatation associated with bicuspid aortic
valve disease.2,3 An improved understanding of these
pathways has clinical relevance to surgeons. With this
knowledge, it may be possible to predict the progression of
aortic dilatation, and in so doing guide both the timing and
extent of aortic resection for individual patients. The current
guidelines for aortic resection in patients with aortopathy
are too simple. Contemporary guidelines rely exclusively on
aortic dimensions without accounting for the degree of
underlying aortopathy (tissue characteristics), disease
phenotype (pattern of cusp fusion), or hemodynamic shear
stress at the level of an individual patient. Personally
tailored approaches for patients with bicuspid aortic
syndrome are crucial because the disease is clinically
heterogeneous, making individual predictions particularly
challenging.4
In their report in this issue of the Journal, Ikonomidis and
colleagues provide a unique set of clinical data that may fa-
cilitate a more accurate and scientific approach to patients
with bicuspid aortic valves. In the search for predictive bio-
markers, these investigators wisely examined previously
implicated ECM regulatory molecules. In addition, a profile
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tive work gives rise to numerous implications. First, these
data confirm the important mechanistic role of ECM dysre-
gulation in the bicuspid aorta, particularly the matrix
metalloproteinase-2/tissue inhibitor of metalloproteinase-2
axis. The link between specific microRNA species and spe-
cific ECM proteases in patients with aortopathy requires
further investigation. Second, the investigation demon-
strates that the bicuspid valve aorta has a molecular signa-
ture different from that of the tricuspid valve aorta in both
the local aortic and remote plasma compartments. These
data provide a proof of concept and suggest that further
work may be capable of validating specific circulating
biomarkers for accurate prediction of future aortic events
in patients with bicuspid aortopathy. A combination of cir-
culating biomarkers with state-of-the art noninvasive struc-
tural and hemodynamic assessments, such as those obtained
with 4-dimensional magnetic resonance imaging,6 might
substantially alter the timing and extent of resection in pa-
tients at risk of aortic events.
In a recent survey, we were somewhat surprised to find
a wide variation in surgeons’ approaches to the aorta in pa-
tients with bicuspid valves. These approaches often went
outside established guidelines, with marked differences in
the timing, extent, and type of operative strategy of aortic
resection. The work of Ikonomidis and colleagues brings
us a step closer to establishing biomarkers as a predictive
tool that may help define clinical phenotypes and establish
best practices for surgical therapy for the large group of
patients with bicuspid aortic valves.
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